AGRXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:18):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
本日の出来高	15 014.00
平均出来高	731 669
時価総額	2.75M
EPS	$-1.510 ( 2024-03-28 )
次の収益日	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0120 (2.99%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.59
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc 相関

10 最も正の相関
PXS	0.967
IONM	0.964
IVAC	0.959
KPTI	0.958
KPRX	0.953
ENTA	0.952
AACG	0.952
NSTG	0.948
RVSN	0.947
PRQR	0.947

10 最も負の相関
VRSK	-0.961
EVLV	-0.953
BTWN	-0.952
QTRX	-0.949
PKOH	-0.946
IMTX	-0.944
PRSR	-0.938
SPNS	-0.936
MDRRP	-0.935
AMZN	-0.933

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Agile Therapeutics Inc 財務諸表

Annual	2023
収益:	$19.59M
総利益:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
収益:	$19.59M
総利益:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
収益:	$10.88M
総利益:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
収益:	$4.10M
総利益:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.